Literature DB >> 8877790

Two cardiac natriuretic peptide genes (atrial natriuretic peptide and brain natriuretic peptide) are organized in tandem in the mouse and human genomes.

N Tamura1, Y Ogawa, A Yasoda, H Itoh, Y Saito, K Nakao.   

Abstract

Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP), which act as cardiac hormones, are produced mainly by the atrium and ventricle, respectively, and are involved in body fluid homeostasis and blood pressure control. The ANP and BNP gene expressions are markedly augmented in ventricles of patients with a wide variety of cardiovascular diseases. It has been demonstrated that the ANP and BNP genes are tightly linked on mouse chromosome 4 and on the distal short arm of human chromosome 1. However, the precise physical map of the ANP and BNP genes has never been elucidated. In the present study, we characterized the genomic DNA fragment containing the ANP and BNP genes in mice and humans. Three genomic DNA clones harboring the entire mouse BNP gene were isolated from a 129/Sv mouse genomic DNA library. Nucleotide sequence analysis revealed that a phage clone (lambda mBNP #3) contains at its 3'-end the 5'-flanking region and the first 209-bp sequence of the first exon of the mouse ANP gene. In mice, the BNP gene was located about 12 kb upstream of the ANP gene. By polymerase chain reaction, we isolated an approximately 11-kb human genomic DNA fragment containing the third exon of the BNP gene and the first and second exons of the ANP gene. In humans, the BNP gene was located upstream of the ANP gene, approximately 8 kb apart. The present study provides the direct evidence that the ANP and BNP genes are organized in tandem in the mouse and human genomes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8877790     DOI: 10.1006/jmcc.1996.0170

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  12 in total

1.  Expression of B-type natriuretic peptide in atrial natriuretic peptide gene disrupted mice.

Authors:  M Y Tse; J D Watson; I R Sarda; T G Flynn; S C Pang
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

2.  Rapid detection of natriuretic peptides by a microfluidic LabChip analyzer with DNA aptamers: Application of natriuretic peptide detection.

Authors:  Ming-Cheng Lin; Jiraporn Nawarak; Tai-Yuan Chen; Hsien-Yu Tsai; Jung-Feng Hsieh; Supachok Sinchaikul; Shui-Tein Chen
Journal:  Biomicrofluidics       Date:  2009-07-30       Impact factor: 2.800

Review 3.  The multifaceted role of natriuretic peptides in metabolic syndrome.

Authors:  Prasanna K Santhekadur; Divya P Kumar; Mulugeta Seneshaw; Faridoddin Mirshahi; Arun J Sanyal
Journal:  Biomed Pharmacother       Date:  2017-06-07       Impact factor: 6.529

4.  Dwarfism and early death in mice lacking C-type natriuretic peptide.

Authors:  H Chusho; N Tamura; Y Ogawa; A Yasoda; M Suda; T Miyazawa; K Nakamura; K Nakao; T Kurihara; Y Komatsu; H Itoh; K Tanaka; Y Saito; M Katsuki; K Nakao
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

Review 5.  Vasopeptidase inhibitors: will they have a role in clinical practice?

Authors:  Matthew I Worthley; Roberto Corti; Stephen G Worthley
Journal:  Br J Clin Pharmacol       Date:  2004-01       Impact factor: 4.335

Review 6.  Translational research of novel hormones: lessons from animal models and rare human diseases for common human diseases.

Authors:  Kazuwa Nakao; Akihiro Yasoda; Ken Ebihara; Kiminori Hosoda; Masashi Mukoyama
Journal:  J Mol Med (Berl)       Date:  2009-10       Impact factor: 4.599

Review 7.  Natriuretic peptides as biomarkers in heart failure.

Authors:  James L Januzzi
Journal:  J Investig Med       Date:  2013-08       Impact factor: 2.895

8.  Emerging Roles of Natriuretic Peptides and their Receptors in Pathophysiology of Hypertension and Cardiovascular Regulation.

Authors:  Kailash N Pandey
Journal:  J Am Soc Hypertens       Date:  2008 Jul-Aug

Review 9.  Bacterial heat-stable enterotoxins: translation of pathogenic peptides into novel targeted diagnostics and therapeutics.

Authors:  Jieru E Lin; Michael Valentino; Glen Marszalowicz; Michael S Magee; Peng Li; Adam E Snook; Brian A Stoecker; Chang Chang; Scott A Waldman
Journal:  Toxins (Basel)       Date:  2010-08-05       Impact factor: 4.546

Review 10.  Guanylyl cyclase/natriuretic peptide receptor-A signaling antagonizes phosphoinositide hydrolysis, Ca(2+) release, and activation of protein kinase C.

Authors:  Kailash N Pandey
Journal:  Front Mol Neurosci       Date:  2014-08-22       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.